Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
Intelligent Bio Solutions (Nasdaq: INBS) has expanded its non-invasive drug testing portfolio with the addition of the SmarTest庐 Patch, a wearable device developed by SMARTOX庐. The innovative patch enables continuous drug detection through sweat over 7-10 days and can detect substances including cocaine, opiates, methamphetamines, marijuana, and fentanyl.
The water-resistant and tamper-evident patch complements INBS's flagship Intelligent Fingerprinting Drug Testing Solution, offering customers flexibility in detection timeframes while maintaining a non-invasive approach. The product expansion particularly targets justice and rehabilitation settings outside the U.S., strengthening the company's position in the non-invasive testing market.
Intelligent Bio Solutions (Nasdaq: INBS) ha ampliato il suo portafoglio di test antidroga non invasivi con l'introduzione del SmarTest庐 Patch, un dispositivo indossabile sviluppato da SMARTOX庐. Questo innovativo cerotto consente la rilevazione continua di sostanze attraverso il sudore per un periodo di 7-10 giorni e pu貌 identificare sostanze come cocaina, oppiacei, metanfetamine, marijuana e fentanyl.
Il cerotto, resistente all'acqua e con sistema di sicurezza anti-manomissione, integra la soluzione principale di Intelligent Bio Solutions, l'Intelligent Fingerprinting Drug Testing Solution, offrendo ai clienti maggiore flessibilit脿 nei tempi di rilevazione, mantenendo un approccio non invasivo. Questa espansione del prodotto 猫 rivolta in particolare ai contesti giudiziari e di riabilitazione al di fuori degli Stati Uniti, rafforzando la posizione dell'azienda nel mercato dei test non invasivi.
Intelligent Bio Solutions (Nasdaq: INBS) ha ampliado su portafolio de pruebas de detecci贸n de drogas no invasivas con la incorporaci贸n del SmarTest庐 Patch, un dispositivo port谩til desarrollado por SMARTOX庐. Este innovador parche permite la detecci贸n continua de drogas a trav茅s del sudor durante 7-10 d铆as y puede identificar sustancias como coca铆na, opi谩ceos, metanfetaminas, marihuana y fentanilo.
El parche, resistente al agua y con protecci贸n contra manipulaciones, complementa la soluci贸n principal de INBS, Intelligent Fingerprinting Drug Testing Solution, ofreciendo a los clientes flexibilidad en los per铆odos de detecci贸n manteniendo un m茅todo no invasivo. Esta expansi贸n de producto est谩 dirigida especialmente a entornos judiciales y de rehabilitaci贸n fuera de los Estados Unidos, fortaleciendo la posici贸n de la compa帽铆a en el mercado de pruebas no invasivas.
Intelligent Bio Solutions (雮橃姢雼�: INBS)電� SMARTOX庐鞐愳劀 臧滊皽頃� 鞗柎霟笖 旮瓣赴鞚� SmarTest庐 Patch毳� 於旉皜頃橃棳 牍勳龚鞀奠爜 鞎诫 瓴�靷� 鞝滍拡甑办潉 頇曥灔頄堨姷雼堧嫟. 鞚� 順侅嫚鞝侅澑 韺箻電� 霑�鞚� 韱淀暣 7-10鞚� 霃欖晥 歆�靻嶌爜鞙茧 鞎诫鞚� 臧愳頃� 靾� 鞛堨溂氅�, 旖旍勾鞚�, 鞎勴幐鞝�, 氅旍姢鞎旐帢韮�氙�, 毵堧Μ頇旊倶, 韼滍儉雼� 霌膘潣 氍检鞚� 韮愳頃� 靾� 鞛堨姷雼堧嫟.
氚╈垬 氚� 氤�臁� 氚╈ 旮半姤鞚� 鞛堧姅 鞚� 韺箻電� INBS鞚� 欤茧牓 鞝滍拡鞚� Intelligent Fingerprinting Drug Testing Solution鞚� 氤挫檮頃橃棳, 牍勳龚鞀奠爜 氚╈嫕鞚� 鞙犾頃橂┐靹� 瓴�靷� 旮瓣皠鞐� 雽�頃� 鞙犾棸靹膘潉 瓿犼皾鞐愱矊 鞝滉车頃╇媹雼�. 鞚� 鞝滍拡 頇曥灔鞚� 韸鬼瀳 氙戈淡 鞕胳潣 靷矔 氚� 鞛櫆 頇橁步鞚� 雽�靸侅溂搿� 頃橃棳, 牍勳龚鞀� 瓴�靷� 鞁滌灔鞐愳劀 須岇偓鞚� 鞛呾毳� 臧曧檾頃╇媹雼�.
Intelligent Bio Solutions (Nasdaq : INBS) a 茅largi son portefeuille de tests de d茅pistage de drogues non invasifs avec l'ajout du SmarTest庐 Patch, un dispositif portable d茅velopp茅 par SMARTOX庐. Ce patch innovant permet une d茅tection continue des drogues via la sueur sur une p茅riode de 7 脿 10 jours et peut d茅tecter des substances telles que la coca茂ne, les opiac茅s, les m茅thamph茅tamines, la marijuana et le fentanyl.
Le patch, r茅sistant 脿 l'eau et anti-manipulation, compl猫te la solution phare d'INBS, Intelligent Fingerprinting Drug Testing Solution, offrant aux clients une flexibilit茅 dans les d茅lais de d茅tection tout en conservant une approche non invasive. Cette extension de produit cible particuli猫rement les milieux judiciaires et de r茅habilitation en dehors des 脡tats-Unis, renfor莽ant la position de l'entreprise sur le march茅 des tests non invasifs.
Intelligent Bio Solutions (Nasdaq: INBS) hat sein Portfolio an nicht-invasiven Drogentests mit der Einf眉hrung des SmarTest庐 Patch, einem von SMARTOX庐 entwickelten tragbaren Ger盲t, erweitert. Das innovative Pflaster erm枚glicht eine kontinuierliche Drogenerkennung 眉ber Schwei脽 f眉r 7-10 Tage und kann Substanzen wie Kokain, Opiate, Methamphetamine, Marihuana und Fentanyl nachweisen.
Das wasserfeste und manipulationssichere Pflaster erg盲nzt die Hauptl枚sung von INBS, die Intelligent Fingerprinting Drug Testing Solution, und bietet Kunden Flexibilit盲t bei den Nachweiszeitr盲umen bei gleichzeitiger Beibehaltung eines nicht-invasiven Ansatzes. Die Produkterweiterung richtet sich insbesondere an Justiz- und Rehabilitationsbereiche au脽erhalb der USA und st盲rkt die Position des Unternehmens im Markt f眉r nicht-invasive Tests.
- Addition of new product (SmarTest Patch) expanding the company's testing solutions portfolio
- Extended detection window of 7-10 days enhances market opportunities in justice and rehabilitation sectors
- Complementary product offering provides greater flexibility and choice for customers
- Expansion into longer-term detection market segments
- Product currently limited to markets outside the U.S.
Insights
INBS expands non-invasive testing portfolio with extended-wear drug detection patch, strengthening market position and addressing longer detection needs.
Intelligent Bio Solutions has strategically expanded its product portfolio by adding the SmarTest Patch, a significant advancement in non-invasive drug testing technology. This innovative wearable device represents a meaningful expansion of the company's testing capabilities, extending detection windows from hours to 7-10 days of continuous monitoring.
The technical differentiation here is substantial. While INBS's flagship Intelligent Fingerprinting system provides point-in-time detection through fingerprint sweat, the SmarTest Patch enables continuous monitoring through a water-resistant, tamper-evident wearable that collects sweat over an extended period. This provides complementary detection windows that address different use cases while maintaining the non-invasive approach that distinguishes INBS from traditional testing methods.
Most notably, this addition positions INBS to penetrate markets where extended detection periods are critical requirements, particularly in justice and rehabilitation settings. The expanded substance detection range (cocaine, opiates, methamphetamines, marijuana, fentanyl, and others) maintains competitive coverage while the extended timeframe opens new application possibilities.
This product addition demonstrates INBS's commitment to strengthening its position in non-invasive testing solutions by providing customers with more flexible options across different detection timeframes. The company appears to be building a more comprehensive ecosystem of complementary testing solutions rather than relying solely on its original technology platform.
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of the SmarTest庐 Patch to its portfolio of non-invasive drug testing solutions. The SmarTest Patch is an innovative wearable device, developed by SMARTOX庐, that enables continuous drug detection through sweat over a 7 to 10-day period. The SmarTest Patch complements the Company's flagship product, the Intelligent Fingerprinting Drug Testing Solution, strengthening its product portfolio of sweat-based, non-invasive testing technologies.
The SmarTest Patch is a discreet, water-resistant, and tamper-evident device worn on the skin for 7 to 10 days at a time, continuously collecting sweat to detect a broad range of substances, including cocaine, opiates, methamphetamines, marijuana and fentanyl, among others. The differing detection windows of the SmarTest Patch and the Intelligent Fingerprinting Drug Screening System allows INBS to address varied customer requirements across timeframes, while maintaining a consistent, non-invasive approach. The complementary products increase flexibility and choice for customers, strengthening the Company鈥檚 position as a leading provider of pain-free testing solutions.
鈥淭he SmarTest Patch opens up new opportunities for us in markets where longer detection windows are critical, particularly in justice and rehabilitation settings,鈥� said Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions. 鈥淚t allows us to offer a more flexible and complete solution to our customers outside the U.S. and strengthens our position as demand continues to grow for non-invasive drug testing options.鈥�
The addition of the SmarTest Patch expands the Company's product offering and enhances its commercial edge, equipping customers with more adaptable tools to support short and long-term detection needs.
About SMARTOX
SMARTOX, founded in 2012, is a U.S.-based provider of drug and alcohol testing products and services. It offers a comprehensive portfolio supporting a wide range of settings, including healthcare, justice, corporate, and education. SMARTOX is committed to delivering advanced technology and exceptional results, providing fully integrated services encompassing design, customer service, and administrative support for its product line. The company's footprint spans the U.S. and international markets. SMARTOX is actively scaling its presence in forensic testing markets through new investments, pilot programs, and expanded jurisdictional coverage.
About Intelligent Bio Solutions Inc.听
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company鈥檚 current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
For more information, visit http://www.ibs.inc/
Forward-Looking Statements
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.鈥檚 ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including 鈥渂elieves,鈥� 鈥渆stimates,鈥� 鈥渁nticipates,鈥� 鈥渆xpects,鈥� 鈥減lans,鈥� 鈥減rojects,鈥� 鈥渋ntends,鈥� 鈥減otential,鈥� 鈥渕ay,鈥� 鈥渃ould,鈥� 鈥渕ight,鈥� 鈥渨ill,鈥� 鈥渟hould,鈥� 鈥渁pproximately鈥� or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions鈥� public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
Company Contact
Intelligent Bio Solutions Inc.鈥�
[email protected] 鈥�
尝颈苍办别诲滨苍鈥瘄鈥疶飞颈迟迟别谤鈥�
Investor & Media Contact
Valter Pinto, Managing Director鈥�
KCSA Strategic Communications鈥�
PH: (212) 896-1254鈥�
[email protected]
FAQ
What is the new SmarTest Patch announced by Intelligent Bio Solutions (INBS)?
How long can the INBS SmarTest Patch be worn?
What drugs can the INBS SmarTest Patch detect?
How does the SmarTest Patch complement INBS's existing drug testing solutions?
Where will INBS's SmarTest Patch be available?
